Personalized Nanomedicine

Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines-that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents within a single formulation, and designed to more specifically deliver drug molecules to pathologic sites-accumulate at the target site, patients likely to respond to nanomedicine-based therapeutic interventions may be preselected. In addition, by longitudinally monitoring how well patients respond to nanomedicine-based therapeutic interventions, drug doses and treatment protocols can be individualized and optimized during follow-up. Furthermore, noninvasive imaging information on the accumulation of nanomedicine formulations in potentially endangered healthy tissues may be used to exclude patients from further treatment. Consequently, combining noninvasive imaging with tumor-targeted drug delivery seems to hold significant potential for personalizing nanomedicine-based chemotherapeutic interventions, to achieve delivery of the right drug to the right location in the right patient at the right time.

  • Nano Medicine in HIV
  • Drug targeting
  • Image-guided drug delivery

Related Conference of Personalized Nanomedicine

April 11-12, 2024

41th Global Nanotechnology Congress

Amsterdam, Netherlands
April 25-26, 2024

36th Nano Congress for Future Advancements

London, UK
May 16-17, 2024

27th World Nanotechnology Congress

Rome, Italy

Personalized Nanomedicine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in